August 11, 2013

BIVI Encourages Swine Vets, Researchers to Submit Proposals for PRRS Research

Company to provide $75,000 to fund three PRRS research studies for 2014

With porcine reproductive and respiratory syndrome (PRRS) costing U.S. swine producers more than $664 million annually in lost production, collaborative scientific research continues to be the industry’s best hope for finding new ways to mitigate this devastating disease.  

For the past 11 years, Boehringer Ingelheim Vetmedica, Inc. (BIVI) has contributed $75,000 annually through its Advancement in PRRS Research Award to fund three selected research studies. According to Michelle Sprague, DVM, president-elect of the American Association of Swine Veterinarians (AASV), results from more than a decade of BIVI-funded research studies have contributed significantly to the industry’s understanding of the disease and how to more effectively manage it.

“After more than 20 years, PRRS continues to be a major disease challenge for swine veterinarians and producers. While we still do not have all of the answers, we have learned a lot about the virus during this time, including how it is transmitted and how to better control it,” Sprague says. “I believe collaborative practical field research will provide valuable information and insight to help us achieve our goal of eradicating PRRS.”

For its 2014 PRRS Research Award, the company is again seeking study proposals from swine veterinarians, diagnosticians and public and private veterinary researchers in the United States, Canada and Mexico. Selected research studies are designed to investigate new ways to diagnose, control and eradicate one of the world’s most costly swine diseases.

BIVI encourages individuals interested in submitting PRRS Research Award proposals to do so by January 1, 2014. Complete details can be found at Research Award recipients will be announced at the AASV annual meeting in Dallas, Texas next March. Proposals will be reviewed by an independent scientific board and awarded based on established criteria including potential economic impact to the swine industry, originality and scientific quality and probability of success in completing the year-long study.

This year, BIVI recognized three veterinarians and researchers for the 2013 Advancement in PRRS Research Award. These recipients were: Gil Patterson, DVM, Swine Vet Center, St. Peter, Minn.; Susan Detmer, DVM, Ph.D., University of Saskatchewan, Saskatoon, Canada; and Locke Karriker, DVM, M.S., Dipl. ACVPM, Iowa State University, Ames, Iowa.

To participate in the PRRS Research Award Program, submit a proposal, cover sheet, curriculum vitae and two letters of recommendation by January 1, 2014, to:

Boehringer Ingelheim Vetmedica, Inc.
Attn: Trudy Luther
The Advancement in PRRS Research Award
3902 Gene Field Rd.
St. Joseph, Mo. 64506 USA

For more information and complete submission instructions, please visit the PRRS Research Award website at

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors.

In 2012, Boehringer Ingelheim achieved net sales of about 14.7 billion euro. R&D expenditure in the business area Prescription Medicines corresponds to 22.5% of its net sales.

For more information about Boehringer Ingelheim, please visit

Contact Information

  • Boehringer Ingelheim Vetmedica, Inc.

    3902 Gene Field Road
    St. Joseph, Missouri 64506